Pioglitazone HCL 15 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FNWQF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,139
Award facts
- Contract value 100% obligated
- $9,139.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,139.20 to supply Pioglitazone HCL 15 mg tablets (quantity: 90 count) with delivery to the company's distribution facility in Conshohocken, Pennsylvania. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and carries an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts with the Defense Logistics Agency and supports military and veteran healthcare systems. The company's federal contracting history demonstrates consistent capability to deliver a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The Pioglitazone HCL order aligns with the company's established role in supplying diabetes and metabolic condition medications to support Defense Health Agency and broader federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FNWQF?
SPE2DB25FNWQF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FNWQF worth?
The government has obligated $9,139 on SPE2DB25FNWQF.
Is contract SPE2DB25FNWQF an order under another contract?
Yes. SPE2DB25FNWQF is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWQF competed?
The extent of competition for SPE2DB25FNWQF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award